Cholestatic jaundice in infancy: struggling with many old and new phenotypes
Author:
Publisher
Springer Science and Business Media LLC
Subject
General Medicine
Link
http://link.springer.com/content/pdf/10.1186/s13052-019-0679-x.pdf
Reference12 articles.
1. Dani C, Pratesi S, Raimondi F, Romagnoli C. On behalf of the task force for hyperbilirubinemia of the Italian Society of Neonatology. Italian guidelines for the management and treatment of neonatal cholestasis. Ital J Pediatr. 2015;41:69.
2. Catzola A, Vajro P. Management options for cholestatic liver disease in children. Expert Rev Gastroenterol Hepatol. 2017;11:1019–30.
3. Fawaz R, Baumann U, Ekong U, Fischler B, Hadzic N, Mack CL, et al. Guideline for the evaluation of Cholestatic jaundice in infants: joint recommendations of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition (NASPGHAN) and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition (ESPGHAN). J Pediatr Gastroenterol Nutr. 2017;64:154–68.
4. American Academy of Pediatrics. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics. 2004;114:297–316.
5. Nicastro E, D’Antiga L. Next generation sequencing in pediatric hepatology and liver transplantation. Liver Transpl. 2018;24:282–93.
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. ZFYVE19 gene mutation: A novel variant of progressive familial intrahepatic cholestasis;JPGN Reports;2024-08-06
2. What's new in pediatric genetic cholestatic liver disease: advances in etiology, diagnostics and therapeutic approaches;Current Opinion in Pediatrics;2024-06-14
3. Treatment with an ileal bile acid transporter inhibitor in patients with TJP2 deficiency;Clinics and Research in Hepatology and Gastroenterology;2023-10
4. Case Report: Add-on treatment with odevixibat in a new subtype of progressive familial intrahepatic cholestasis broadens the therapeutic horizon of genetic cholestasis;Frontiers in Pediatrics;2023-02-14
5. The Landscape of HNF1B Deficiency: A Syndrome Not Yet Fully Explored;Cells;2023-01-13
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3